Article Menu
-
Academic Editors
Angelos Hatzakis
Michal Herman-Edelstein
- Subscribe SciFeed
- Recommended Articles
- Related Info Links
-
More by Authors Links
- on DOAJ
- Rabinowitz, K. Masha
- Navon, M.
- Edelman-Klapper, H.
- Zittan, E.
- Bar-Gil Shitrit, A.
- Goren, I.
- Avni-Biron, I.
- Ollech, J. E.
- Lichtenstein, L.
- Banai-Eran, H.
- Yanai, H.
- Snir, Y.
- Pauker, M. H.
- Friedenberg, A.
- Levy-Barda, A.
- Segal, A.
- Broitman, Y.
- Maoz, E.
- Ovadia, B.
- Aharoni Golan, M.
- Shachar, E.
- Ben-Horin, S.
- Maharshak, N.
- Mor, M.
- Ben Zvi, H.
- Eliakim, R.
- Barkan, R.
- Sharar-Fischler, T.
- Goren, S.
- Krugliak, N.
- Pichinuk, E.
- Mor, M.
- Werbner, M.
- Alter, J.
- Abu-Taha, H.
- Kaboub, K.
- Dessau, M.
- Gal-Tanamy, M.
- Cohen, D.
- Freund, N. T.
- Dotan, I.
- on behalf of the Responses to COVID-19 Vaccine Israeli IBD Group, .
- on Google Scholar
- Rabinowitz, K. Masha
- Navon, M.
- Edelman-Klapper, H.
- Zittan, E.
- Bar-Gil Shitrit, A.
- Goren, I.
- Avni-Biron, I.
- Ollech, J. E.
- Lichtenstein, L.
- Banai-Eran, H.
- Yanai, H.
- Snir, Y.
- Pauker, M. H.
- Friedenberg, A.
- Levy-Barda, A.
- Segal, A.
- Broitman, Y.
- Maoz, E.
- Ovadia, B.
- Aharoni Golan, M.
- Shachar, E.
- Ben-Horin, S.
- Maharshak, N.
- Mor, M.
- Ben Zvi, H.
- Eliakim, R.
- Barkan, R.
- Sharar-Fischler, T.
- Goren, S.
- Krugliak, N.
- Pichinuk, E.
- Mor, M.
- Werbner, M.
- Alter, J.
- Abu-Taha, H.
- Kaboub, K.
- Dessau, M.
- Gal-Tanamy, M.
- Cohen, D.
- Freund, N. T.
- Dotan, I.
- on behalf of the Responses to COVID-19 Vaccine Israeli IBD Group, .
- on PubMed
- Rabinowitz, K. Masha
- Navon, M.
- Edelman-Klapper, H.
- Zittan, E.
- Bar-Gil Shitrit, A.
- Goren, I.
- Avni-Biron, I.
- Ollech, J. E.
- Lichtenstein, L.
- Banai-Eran, H.
- Yanai, H.
- Snir, Y.
- Pauker, M. H.
- Friedenberg, A.
- Levy-Barda, A.
- Segal, A.
- Broitman, Y.
- Maoz, E.
- Ovadia, B.
- Aharoni Golan, M.
- Shachar, E.
- Ben-Horin, S.
- Maharshak, N.
- Mor, M.
- Ben Zvi, H.
- Eliakim, R.
- Barkan, R.
- Sharar-Fischler, T.
- Goren, S.
- Krugliak, N.
- Pichinuk, E.
- Mor, M.
- Werbner, M.
- Alter, J.
- Abu-Taha, H.
- Kaboub, K.
- Dessau, M.
- Gal-Tanamy, M.
- Cohen, D.
- Freund, N. T.
- Dotan, I.
- on behalf of the Responses to COVID-19 Vaccine Israeli IBD Group, .
Need Help?
Order Article Reprints
Journal: Vaccines, 2022
Volume: 10
Number: 1186
1186
Article:
Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases
Authors:
by
Keren Masha Rabinowitz, Michal Navon, Hadar Edelman-Klapper, Eran Zittan, Ariella Bar-Gil Shitrit, Idan Goren, Irit Avni-Biron, Jacob E. Ollech, Lev Lichtenstein, Hagar Banai-Eran, Henit Yanai, Yifat Snir, Maor H. Pauker, Adi Friedenberg, Adva Levy-Barda, Arie Segal, Yelena Broitman, Eran Maoz, Baruch Ovadia, Maya Aharoni Golan, Eyal Shachar, Shomron Ben-Horin, Nitsan Maharshak, Michal Mor, Haim Ben Zvi, Rami Eliakim, Revital Barkan, Tali Sharar-Fischler, Sophy Goren, Noy Krugliak, Edward Pichinuk, Michael Mor, Michal Werbner, Joel Alter, Hanan Abu-Taha, Kawsar Kaboub, Moshe Dessau, Meital Gal-Tanamy, Dani Cohen, Natalia T. Freund, Iris Dotan and on behalf of the Responses to COVID-19 Vaccine Israeli IBD Groupadd
Show full author list
remove
Hide full author list
Link:
https://www.mdpi.com/2076-393X/10/8/1186
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.
Cite
Rabinowitz, K.M.; Navon, M.; Edelman-Klapper, H.; Zittan, E.; Bar-Gil Shitrit, A.; Goren, I.; Avni-Biron, I.; Ollech, J.E.; Lichtenstein, L.; Banai-Eran, H.; et al. Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases. Vaccines 2022, 10, 1186. https://doi.org/10.3390/vaccines10081186
Rabinowitz KM, Navon M, Edelman-Klapper H, Zittan E, Bar-Gil Shitrit A, Goren I, Avni-Biron I, Ollech JE, Lichtenstein L, Banai-Eran H, et al. Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases. Vaccines. 2022; 10(8):1186. https://doi.org/10.3390/vaccines10081186
Chicago/Turabian StyleRabinowitz, Keren Masha, Michal Navon, Hadar Edelman-Klapper, Eran Zittan, Ariella Bar-Gil Shitrit, Idan Goren, Irit Avni-Biron, Jacob E. Ollech, Lev Lichtenstein, Hagar Banai-Eran, and et al. 2022. "Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases" Vaccines 10, no. 8: 1186. https://doi.org/10.3390/vaccines10081186
APA StyleRabinowitz, K. M., Navon, M., Edelman-Klapper, H., Zittan, E., Bar-Gil Shitrit, A., Goren, I., Avni-Biron, I., Ollech, J. E., Lichtenstein, L., Banai-Eran, H., Yanai, H., Snir, Y., Pauker, M. H., Friedenberg, A., Levy-Barda, A., Segal, A., Broitman, Y., Maoz, E., Ovadia, B., ... on behalf of the Responses to COVID-19 Vaccine Israeli IBD Group. (2022). Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases. Vaccines, 10(8), 1186. https://doi.org/10.3390/vaccines10081186
